US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 14, 2019 (7 years ago)

RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.

What was recalled

RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b) 12-count (2 cards x 6 tablets) per carton, NDC 0049-2340-05, Rx only, Made in Ireland, Distributed by Pfizer Roerig, Division of Pfizer Inc., NY, NY 10017.

Recalling firm
Pfizer Inc.
NDC code
0049-2340-45
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1845-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Eletriptan recalls

See all